List of Excipients in API deutetrabenazine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing deutetrabenazine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Teva Neuroscience Inc | AUSTEDO | deutetrabenazine | 68546-170 | AMMONIA | 2034-03-18 |
Teva Neuroscience Inc | AUSTEDO | deutetrabenazine | 68546-170 | BUTYL ALCOHOL | 2034-03-18 |
Teva Neuroscience Inc | AUSTEDO | deutetrabenazine | 68546-170 | BUTYLATED HYDROXYANISOLE | 2034-03-18 |
Teva Neuroscience Inc | AUSTEDO | deutetrabenazine | 68546-170 | BUTYLATED HYDROXYTOLUENE | 2034-03-18 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for deutetrabenazine
Excipient focus: AMMONIA
deutetrabenazine drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
deutetrabenazine drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
deutetrabenazine drug variants containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
deutetrabenazine drug variants containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
deutetrabenazine drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
deutetrabenazine drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
deutetrabenazine drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
deutetrabenazine drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
deutetrabenazine drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
deutetrabenazine drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
deutetrabenazine drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 2000000
deutetrabenazine drug variants containing POLYETHYLENE GLYCOL 2000000
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing POLYETHYLENE GLYCOL 2000000
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
deutetrabenazine drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
deutetrabenazine drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
deutetrabenazine drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
deutetrabenazine drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
deutetrabenazine drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
deutetrabenazine drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
deutetrabenazine drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Neuroscience Inc | deutetrabenazine | 68546-170 |
>Company | >Ingredient | >NDC |
deutetrabenazine drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.